KINIKSA PHARMACEUTICALS LTD

CUSIP: G5269C101 Class: Foreign Stock

Hudson Bay Capital Management LP's Holding History (CIK: 0001393825)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 151,000 Value ($000) $2,979 Avg Close — Range —
Q4 2023
Shares 215,000 Value ($000) $3,771 Avg Close — Range —
Q3 2023
Shares 302,500 Value ($000) $5,254 Avg Close — Range —
Q2 2023
Shares 680,000 Value ($000) $9,574 Avg Close — Range —
Q1 2023
Shares 616,691 Value ($000) $6,636 Avg Close — Range —
Q4 2022
Shares 600,000 Value ($000) $8,988 Avg Close — Range —
Q3 2022
Shares 1,200,000 Value ($000) $15,408 Avg Close — Range —
Q2 2022
Shares 1,375,000 Value ($000) $13,324 Avg Close — Range —
Q1 2022
Shares 1,280,000 Value ($000) $12,723 Avg Close — Range —
Q4 2021
Shares 1,050,000 Value ($000) $12,358 Avg Close — Range —
Q3 2021
Shares 1,150,000 Value ($000) $13,099 Avg Close — Range —
Q2 2021
Shares 800,000 Value ($000) $11,144 Avg Close — Range —
Q1 2021
Shares 495,000 Value ($000) $9,162 Avg Close — Range —
Q4 2020
Shares 600,000 Value ($000) $10,602 Avg Close — Range —
Q3 2020
Shares 450,000 Value ($000) $6,894 Avg Close — Range —
Q2 2020
Shares 185,000 Value ($000) $4,713 Avg Close — Range —
Q1 2020
Shares 230,000 Value ($000) $3,560 Avg Close — Range —
Q4 2019
Shares 440,000 Value ($000) $4,866 Avg Close — Range —
Q3 2019
Shares 130,000 Value ($000) $1,106 Avg Close — Range —
Q2 2019
Shares 115,000 Value ($000) $1,557 Avg Close — Range —
Q1 2019
Shares 90,000 Value ($000) $1,625 Avg Close — Range —